Levi & Korsinsky Invites Revance Therapeutics Shareholders to Join Class Action Lawsuit
Join the Fight: Revance Therapeutics Shareholders Class Action Lawsuit
Revance Therapeutics, Inc. (NASDAQ: RVNC) is currently the subject of a class action lawsuit, and investors who suffered losses during a specific period are encouraged to take action. The law firm Levi & Korsinsky, LLP, known for its extensive experience in securities litigation, is spearheading this initiative to protect shareholders who may have been impacted by alleged securities fraud.
Case Background
The class action aims to represent shareholders who experienced financial losses between February 29, 2024, and December 6, 2024. According to the lawsuit details, several critical allegations have been laid against Revance.
1. Breach of Agreement: It is claimed that Revance breached its Distribution Agreement with Teoxane, which provided it with exclusive rights to market and distribute Teoxane's dermal fillers. This breach could expose Revance to increased litigation risk as well as monetary and reputational damage.
2. Misleading Statements: The lawsuit asserts that the company's public disclosures during this timeframe were materially false and misleading, which could have influenced the stock's performance and misled investors about the company's health and business practices.
3. Risk Factors: The claims highlight that the aforementioned issues might delay or amend a crucial tender offer, further complicating the financial landscape for shareholders.
Key Dates
Affected shareholders have a limited time to act. You have until March 4, 2025, to request that the court appoint you as a lead plaintiff. It’s important to note that you can still recover without being a lead plaintiff.
No Costs to Participants
One of the most compelling aspects of this action is that investors can participate without any financial obligation. Levi & Korsinsky assures that class members may be entitled to compensation without upfront costs or the need for out-of-pocket expenses. This enables more shareholders to be part of the lawsuit without the fear of incurring legal fees.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has built a strong reputation over the past two decades, having secured hundreds of millions of dollars for aggrieved investors. Their expertise in handling complex securities litigation sets them apart in the legal landscape. For the last seven years, the firm has been recognized in the Top 50 Report by ISS Securities Class Action Services, solidifying its position as a leading law firm in this domain.
To get involved or to learn more about your rights as a shareholder of Revance Therapeutics, interested individuals should reach out to Joseph E. Levi, Esq. at his office in New York or visit their website for more details.
Contact Information
- - Website: Levi & Korsinsky
- - Email: [email protected]
- - Phone: (212) 363-7500
- - Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
Conclusion
If you are a shareholder of Revance Therapeutics and believe you have been affected by these issues, now is the time to take action. Joining the class action lawsuit can be a step towards recovering your losses and holding the company accountable for any mismanagement or fraudulent activities that may have transpired during this period. Don’t hesitate to connect with Levi & Korsinsky to secure your right to participate.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.